Loading...
Loading...
Among the 5 tracked institutional investors we monitor, SOPH (SOPHIA GENETICS SA) is held with a combined value of $18.93M across 3,823,368 shares. The largest holder is AKRE CAPITAL MANAGEMENT LLC with a position worth $18.41M (0.30% of their portfolio). CITADEL ADVISORS LLC opened a new position in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$18.93M
Total Shares Held
3,823,368
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | AKRE CAPITAL MANAGEMENT LLC | $18.41M | 0.30% | - |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $296.01K | 0.00% | -28.0% |
| 3 | CITADEL ADVISORS LLC | $144.54K | 0.00% | New |
| 4 | MILLENNIUM MANAGEMENT LLC | $50.20K | 0.00% | -91.9% |
| 5 | BlackRock, Inc. | $25.18K | 0.00% | - |
As of the latest SEC 13F filings, AKRE CAPITAL MANAGEMENT LLC is the largest institutional holder of SOPH with a position worth $18.41M, representing 0.30% of their portfolio. In total, 5 institutional investors hold SOPH with a combined value of $18.93M.
In the most recent quarter, 1 fund opened a new position in SOPH. Additionally, 2 reduced their positions.
Institutional investors hold $18.93M worth of SOPH stock across 5 positions. The largest institutional holder is AKRE CAPITAL MANAGEMENT LLC with $18.41M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SOPH, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SOPH positions.